Ushbu ish iqtibos qilgan ishlar

186 ta ish

Ish: Unraveling the microbiome’s role in breast cancer progression and treatment response

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Sharh maqola201118 iqtibos
ABI
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67
Maqola20176 iqtibos
ABI
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda +27
Maqola20135 iqtibos
ABI
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45
Maqola20175 iqtibos
ABI
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager, Regula Burkhard, Nicola Pett +10
Maqola20204 iqtibos
ABI
The tumor microenvironment
Nicole Anderson, M. Celeste Simon
Maqola20204 iqtibos
ABI
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Patrick M. Smith, Michael R. Howitt, Nicolai Panikov +5
Maqola20133 iqtibos
ABI
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
M. Janaki Ramaiah, Anjana Devi Tangutur, Rajasekhar Reddy Manyam
Sharh maqola20213 iqtibos
ABI
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian +1
Sharh maqola20203 iqtibos
ABI
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma‐Rodrigues, Rita Mendes, Pedro V. Baptista +1
Sharh maqola20193 iqtibos
ABI
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas, Roberto Salgado, Carsten Denkert +4
Sharh maqola20153 iqtibos
ABI
Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers
Kellen Wright, Thuc Ly, Matthew Kriet +2
Sharh maqola20233 iqtibos
ABI
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin, Ruiqiang Li, Jeroen Raes +50
Maqola20103 iqtibos
ABI
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35
Maqola20153 iqtibos
ABI
Innate immune cells in the tumor microenvironment
Ming O. Li, Natalie K. Wolf, David H. Raulet +8
Maqola20213 iqtibos
ABI
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu, Zeno Riester, Adrian Baldrich +23
Maqola20212 iqtibos
ABI
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou +3
Sharh maqola20212 iqtibos
ABI
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo, Lisa M. Coussens
Sharh maqola20072 iqtibos
ABI
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Tyler J. Curiel, George Coukos, Linhua Zou +18
Maqola20042 iqtibos
ABI
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander, Ian D. Wilson, Julian Teare +3
Sharh maqola20172 iqtibos
ABI
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot +30
Maqola20132 iqtibos
ABI
Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis
Abby L. Geis, Hongni Fan, Xinqun Wu +6
Maqola20152 iqtibos
ABI
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert +9
Maqola20152 iqtibos
ABI
Microbiota: a key orchestrator of cancer therapy
Soumen Roy, Giorgio Trinchieri
Sharh maqola20172 iqtibos
ABI
Anticancer effects of the microbiome and its products
Laurence Zitvogel, Romain Daillère, María Paula Roberti +2
Sharh maqola20172 iqtibos
ABI

Ushbu ish iqtibos qilgan ishlar

Hallmarks of Cancer: The Next Generation

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

The tumor microenvironment

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T <sub>reg</sub> Cell Homeostasis

Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy

Triple-negative breast cancer molecular subtyping and treatment progress

Targeting Tumor Microenvironment for Cancer Therapy

Clinical relevance of host immunity in breast cancer: from TILs to the clinic

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers

A human gut microbial gene catalogue established by metagenomic sequencing

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Innate immune cells in the tumor microenvironment

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Gut microbiota modulation of chemotherapy efficacy and toxicity

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Regulatory T-cell Response to Enterotoxigenic <i>Bacteroides fragilis</i> Colonization Triggers IL17-Dependent Colon Carcinogenesis

Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Microbiota: a key orchestrator of cancer therapy

Anticancer effects of the microbiome and its products